The rising prevalence in GLP-1 agonists for diabetes has led to a debate about formats: transdermal systems versus capsules. Traditionally , GLP-1 therapies were solely available in pill form, but the https://sauljykp358185.thechapblog.com/39821340/glp-1-transdermal-delivery-systems-vs-oral-medications-what-best-for-individuals